574 related articles for article (PubMed ID: 24270264)
1. Role for DNA damage signaling in pulmonary arterial hypertension.
Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
[TBL] [Abstract][Full Text] [Related]
2. miR-223 reverses experimental pulmonary arterial hypertension.
Meloche J; Le Guen M; Potus F; Vinck J; Ranchoux B; Johnson I; Antigny F; Tremblay E; Breuils-Bonnet S; Perros F; Provencher S; Bonnet S
Am J Physiol Cell Physiol; 2015 Sep; 309(6):C363-72. PubMed ID: 26084306
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
5. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
6. PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension.
Lampron MC; Vitry G; Nadeau V; Grobs Y; Paradis R; Samson N; Tremblay È; Boucherat O; Meloche J; Bonnet S; Provencher S; Potus F; Paulin R
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):783-801. PubMed ID: 31969012
[TBL] [Abstract][Full Text] [Related]
7. Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
Meloche J; Lampron MC; Nadeau V; Maltais M; Potus F; Lambert C; Tremblay E; Vitry G; Breuils-Bonnet S; Boucherat O; Charbonneau E; Provencher S; Paulin R; Bonnet S
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1513-1523. PubMed ID: 28473439
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.
Liu HM; Jia Y; Zhang YX; Yan J; Liao N; Li XH; Tang Y
Acta Pharmacol Sin; 2019 Apr; 40(4):477-485. PubMed ID: 30038339
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH.
Courboulin A; Barrier M; Perreault T; Bonnet P; Tremblay VL; Paulin R; Tremblay E; Lambert C; Jacob MH; Bonnet SN; Provencher S; Bonnet S
Eur Respir J; 2012 Sep; 40(3):618-29. PubMed ID: 22496325
[TBL] [Abstract][Full Text] [Related]
10. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
Marsboom G; Toth PT; Ryan JJ; Hong Z; Wu X; Fang YH; Thenappan T; Piao L; Zhang HJ; Pogoriler J; Chen Y; Morrow E; Weir EK; Rehman J; Archer SL
Circ Res; 2012 May; 110(11):1484-97. PubMed ID: 22511751
[TBL] [Abstract][Full Text] [Related]
11. Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.
Meloche J; Potus F; Vaillancourt M; Bourgeois A; Johnson I; Deschamps L; Chabot S; Ruffenach G; Henry S; Breuils-Bonnet S; Tremblay È; Nadeau V; Lambert C; Paradis R; Provencher S; Bonnet S
Circ Res; 2015 Aug; 117(6):525-35. PubMed ID: 26224795
[TBL] [Abstract][Full Text] [Related]
12. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-140-5p targeting tumor necrosis factor-α prevents pulmonary arterial hypertension.
Zhu TT; Zhang WF; Yin YL; Liu YH; Song P; Xu J; Zhang MX; Li P
J Cell Physiol; 2019 Jun; 234(6):9535-9550. PubMed ID: 30367500
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression.
Xing Y; Zheng X; Li G; Liao L; Cao W; Xing H; Shen T; Sun L; Yang B; Zhu D
Int J Biochem Cell Biol; 2015 Jul; 64():155-66. PubMed ID: 25882492
[TBL] [Abstract][Full Text] [Related]
15. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
[TBL] [Abstract][Full Text] [Related]
16. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
17. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.
Miao R; Liu W; Qi C; Song Y; Zhang Y; Fu Y; Liu W; Lang Y; Zhang Y; Zhang Z
Life Sci; 2020 Sep; 257():117919. PubMed ID: 32585247
[TBL] [Abstract][Full Text] [Related]
18. miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA.
Wang P; Xu J; Hou Z; Wang F; Song Y; Wang J; Zhu H; Jin H
Cell Prolif; 2016 Aug; 49(4):484-93. PubMed ID: 27302634
[TBL] [Abstract][Full Text] [Related]
19. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
20. Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase.
Lai YJ; Chang GJ; Yeh YH; Pang JH; Huang CC; Chen WJ
PLoS One; 2015; 10(9):e0137426. PubMed ID: 26367462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
